The blood bags that leave the National Blood Transfusion Center (CNTS) to be transfused to patients are of good quality, according to a study conducted by Dr. Abdoulkarim Barry as part of his thesis. end of study. For his brilliant work, he was judged worthy of the rank of State Doctor of Pharmacy with the congratulations of the jury.
‘After the various results, we noticed better performance from the different laboratories. So, we reassure public opinion about the quality of the blood bags that leave the CNTS,’ declared the applicant during his defense of his state doctoral thesis in pharmacy, on July 13, 2024 in Ouagadougou.
Dr Abdoulkarim Barry worked on the evaluation of the performance of the biological qualification laboratories of donations from regional blood transfusion centers and sampler depots distributing blood products through inter-laboratory control from 2017 to 2023.
The analyzes concerned by this quality control are the screening for human immunodeficiency virus (HIV), hepatitis B virus (H
BV), hepatitis C virus (HCV), syphilis and the determination of ABO/RHD blood group.
According to him, the objective of his research was to know if the blood analysis results from the CNTS laboratories, through all its components, are of good quality and secure for the transfusion needs of patients.
‘The inter-laboratory quality control of the Regional Blood Transfusion Centers (CRTS) and the Sample Distributor Depots (DPD) is satisfactory overall. There is no infectious risk of contamination by using this blood,’ reassured the brand new doctor of pharmacy, Abdoulkarim Barry.
According to Dr. Barry, the CNTS laboratories are efficient because the samples consisting of plasma and whole blood, after analysis, have results almost 100% consistent with the expected results.
However, some non-compliances were noted, mainly linked to hemolyzed blood samples which could not be analyzed by certain laboratories and to errors in transcription of the results.
The inter-laboratory analysis of the samples was carried
out in the CRTS of Ouagadougou, Bobo-Dioulasso, Koudougou, Tenkodogo and Fada N’Gourma, and the DPD of Ouahigouya, Kaya, Gaoua and Dédougou.
The thesis director, Professor Mahamoudou Sanou, full professor in bacteriology-virology at Joseph Ki-Zerbo University, wanted to be reassuring about the laboratory work of the CRTS and DPD.
‘We have the latest generation of devices which do what we call ELISA or electrochemiluminescence with the principles of antigen-antibody reactions, very sensitive and specific, which make it possible to further secure the blood,’ he said. noted.
For him, the CNTS is doing everything possible to have uninfected blood for sick people, children and pregnant women requesting it.
Since zero risk does not exist, Professor Mahamoudou Sanou invited the CNTS to take all precautions and maintain its level of quality in order to avoid contamination in both the donor and the recipient.
‘This involves quality controls at the various regional blood transfusion centers and sampler-distributor
depots,’ explained Professor Sanou.
Given the importance of this precious liquid for patients, Professor Mahamoudou Sanou invited all stakeholders to work to avoid the risk of contamination of applicants and recipients.
He also called on blood donors to tell CNTS agents the truth about their serology, during interview sessions before donating blood. ‘If you have taken a risk as a donor, it is not worth donating blood. We call this donor selection,’ he insisted.
According to the data, 135,818 blood bags were collected throughout Burkina Faso in 2023 by the CNTS.
These blood bags were treated to ensure their safety before being distributed and transfused to patients, mainly children under five and women aged 15 to 49, i.e. 60% of all beneficiaries. , specify the same sources.
Source: Burkina Information Agency